Product NDC: | 0409-2169 |
Proprietary Name: | Digoxin |
Non Proprietary Name: | DIGOXIN |
Active Ingredient(s): | 250 ug/mL & nbsp; DIGOXIN |
Administration Route(s): | INTRAMUSCULAR; INTRAVENOUS |
Dosage Form(s): | INJECTION, SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0409-2169 |
Labeler Name: | Hospira, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA040093 |
Marketing Category: | ANDA |
Start Marketing Date: | 20110331 |
Package NDC: | 0409-2169-32 |
Package Description: | 10 CARTRIDGE in 1 CARTON (0409-2169-32) > 2 mL in 1 CARTRIDGE |
NDC Code | 0409-2169-32 |
Proprietary Name | Digoxin |
Package Description | 10 CARTRIDGE in 1 CARTON (0409-2169-32) > 2 mL in 1 CARTRIDGE |
Product NDC | 0409-2169 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | DIGOXIN |
Dosage Form Name | INJECTION, SOLUTION |
Route Name | INTRAMUSCULAR; INTRAVENOUS |
Start Marketing Date | 20110331 |
Marketing Category Name | ANDA |
Labeler Name | Hospira, Inc. |
Substance Name | DIGOXIN |
Strength Number | 250 |
Strength Unit | ug/mL |
Pharmaceutical Classes | Cardiac Glycoside [EPC],Cardiac Glycosides [Chemical/Ingredient] |